Kotak 
Dealstreet

Kotak PE invests 400 crore in Biorad Medisys: Luthra advises

Kotak Strategic Situations India Fund II invested ₹400 crore.

Bar & Bench

Kotak Strategic Situations India Fund II, managed by Kotak Alternate Asset Managers Limited, has made an investment of up to ₹400 Crore in medical device manufacturer Biorad Medisys Private Limited.

Luthra and Luthra Law Offices India represented Kotak in this investment deal.

The transaction team consisted of Nishant Singh (Partner), Prachi Pandit (Managing Associate), Saksham Madan (Managing Associate), Manushi Shah (Associate), Varshini Ramesh (Associate), Aditi Nagpal (Associate), Charith Reddy (Associate), Kashish Singhal (Associate), Maitri Meghani (Associate) and Aashi Shah (Associate).

Nishant Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Judiciary cannot be beyond scrutiny, criticism necessary for accountability: CJI Surya Kant

Interpol arrest warrant cannot be ignored merely because there is no extradition request: Kerala High Court

What if cash was found in a minister’s house? Harish Salve questions handling of Justice Yashwant Varma episode

J&K Advocate General's post vacant since October 2024; PIL in High Court seeks appointment

Shardul Amarchand Mangaldas & Co elevates 7 Partners to Equity Partnership

SCROLL FOR NEXT